News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Ketamine One to Provide Scent-Enabled Virtual Reality Via Exclusive Agreement for Psychedelic Molecules With OVR Technology
Wellbeing Digital Sciences
PsyBio Therapeutics Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio
PsyBio Therapeutics
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis
Pharmather
Mark Haden, Psychedelic Medicine Expert, Joins Clearmind Medicine’s Advisory Board
Clearmind Medicine
Filament Health Is The First Public Company To Be Issued A Patent For Extraction of Natural psilocybin
Filament Health
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology
Mind Medicine (MindMed)
Justin Hanka | Co-Founder, MindBio Therapeutics
MindBio Therapeutics
Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results
Braxia Scientific Corp.
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements
Red Light Holland
Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
Core One Labs Inc.
Tryp Therapeutics Announces Q3 2021 Financial Results
Tryp Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.